CHICAGO--When pioneering interventional cardiologists introduced angioplasty and stenting more than 20 years ago, few could have imagined that, one day, severely diseased coronary arteries would be ...

Washington, DC - Predicting the future is a fool's game, and predicting successful drug and device therapy in cardiovascular medicine is just as tricky. When bioabsorbable stents emerged on the radar ...

Cardiovascular diseases remain one of the leading causes of illness and mortality worldwide. When heart-related symptoms arise, such as chest pain, shortness of breath, or unexplained fatigue, medical ...

Clinical trial establishes non-inferiority of drug-eluting stent with a bioabsorbable polymer compared to traditional drug-eluting stent with durable polymer San Francisco, CA --A clinical trial has ...

ABBOTT PARK, Ill., March 13, 2008 – Data published today in The Lancet from ABSORB, the world’s first clinical trial of a fully bioabsorbable drug eluting stent for the treatment of coronary artery ...

For about a decade, bioabsorbable stents were hailed as one of the most promising technologies in cardiology. Now, the future prospects of the technology are less than certain after a clinical trial ...

(UPDATED) There is no difference in in-hospital outcomes or longer-term mortality between patients undergoing revascularization with either a durable-polymer DES or newer technology with a ...

An angiogram is a diagnostic procedure to detect conditions affecting the heart and blood vessels. An angioplasty is a curative procedure to treat conditions relating to arterial plaque buildup. An ...

Both the angiogram and angioplasty are useful tools when diagnosing and treating blockages and other heart issues. Both procedures are performed on an outpatient basis and are minimally invasive. If ...